Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bertil Björklund is active.

Publication


Featured researches published by Bertil Björklund.


The Journal of Pathology | 1999

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

Mathie P.G. Leers; Wendy Kölgen; Viveka Björklund; Tomas Bergman; Gordon Tribbick; Bengt Persson; Peter Björklund; Frans C. S. Ramaekers; Bertil Björklund; Marius Nap; Hans Jörnvall; Bert Schutte

A neo‐epitope in cytokeratin 18 (CK18) that becomes available at an early caspase cleavage event during apoptosis and is not detectable in vital epithelial cells is characterized. The monoclonal antibody M30, specific for this site, can be utilized specifically to recognize apoptotic cells, which show cytoplasmic cytokeratin filaments and aggregates after immunohistochemistry with M30, while viable and necrotic cells are negative. The number of cells recognized by the antibody increases after induction of apoptosis in exponentially growing epithelial cell lines and immunoreactivity is independent of the phosphorylation state of the cytokeratins. The generation of the M30 neo‐epitope occurs early in the apoptotic cascade, before annexin V reactivity or positive DNA nick end labelling. In a flow cytometric assay, the majority of the M30‐positive cells appear in the ‘apoptotic’ subG1 peak. Tests with synthetic peptides define positions 387–396 of CK18, with a liberated C‐terminus at the caspase cleavage site DALD‐S, as the ten‐residue epitope of M30. This epitope starts at the end of coil 2 of the predicted CK18 structure, at a probable hinge region, compatible with the sensitivity to proteolytic cleavage. The definition of a specific caspase cleavage site in CK18 as a neo‐epitope can be used for quantification of apoptotic epithelial cells with immunocytochemical techniques and is applicable to both fresh and formalin‐fixed material. Copyright


Experimental Biology and Medicine | 1961

The cytostat, an apparatus for automatically controlled continuous propagation of suspended cells.

Bertil Björklund; Viveka Björklund; Jan-Eric Paulsson

Summary The cytostat and its operation have been described. It would seem to be a useful aid to further in vitro studies of cell populations.


Experimental Biology and Medicine | 1962

Curtain electrophoretic separation of phenyl acetate hydrolysing esterases of human serum. Demonstration of an EDTA-dependent enzyme.

Bertil Björklund; Jan-Eric Paulsson; Sven Ekberg

Summary By repeated continuous flow curtain electrophoresis of human serum, 2 distinct phenyl acetate hydrolyzing esterases were purified 120 and 850 times. One esterase was heat-labile and inactivated by EDTA, while the other was heat-stable and required EDTA for activity. EDTA-inactivation could be prevented by manganese. The methods for purification and assay are described and the results discussed.


Experimental Cell Research | 2004

Keratin 8/18 breakdown and reorganization during apoptosis

Bert Schutte; Mieke Henfling; Wendy Kölgen; Maartje Bouman; Stephan Meex; Mathie P.G. Leers; Marius Nap; Viveka Björklund; Peter Björklund; Bertil Björklund; E. Birgitte Lane; M. Bishr Omary; Hans Jörnvall; Frans C. S. Ramaekers


International Archives of Allergy and Immunology | 1958

Antigenicity of Pooled Human Malignant and Normal Tissues by Cyto-Immunological Technique: II. Nature of Tumor Antigen

Bertil Björklund; Gunnar Lundblad; Viveka Björklund


International Archives of Allergy and Immunology | 1956

Antigenicity of Malignant and Normal Human Tissues by Gel Diffusion Techniques

Bertil Björklund


Apmis | 2009

Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.

Viveka Björklund; Bertil Björklund; Christian Wittekind; Sabine von Kleist


Archive | 1998

Apoptosis-related compounds and their use

Viveka Björklund; Bertil Björklund; Peter Björklund; Marius Nap; Frans C. S. Ramaekers; Bert Schutte


Journal of the National Cancer Institute | 1961

Antigenicity of Pooled Human Malignant and Normal Tissues by Cytoimmunological Technique. III. Distribution of Tumor Antigen

Bertil Björklund; Viveka Björklund; Ingegerd Hedlöf


Acta Medica Scandinavica | 2009

Studies on the effect of anti-bone-marrow-serum.

Bertil Björklund; Lennart Hellström

Collaboration


Dive into the Bertil Björklund's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge